Treatment Outcomes With tDCS in Post-Stroke Aphasia
NCT: NCT03929432 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose this study is to test the utility of pairing external neuromodulation with behavioral language treatment to boost therapy outcomes and to investigate the mechanisms associated with recovery. Because all PWA have word retrieval deficits, this project will test if greater language gains can be achieved by supplementing anomia intervention with excitatory brain stimulation to the left hemisphere and will evaluate associated functional brain changes to aid the optimization of neural reorganization to facilitate language processing.
Frequently Asked Questions
What is Treatment Outcomes With tDCS in Post-Stroke Aphasia?
Treatment Outcomes With tDCS in Post-Stroke Aphasia is a clinical trial registered under NCT03929432. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03929432?
The current status of NCT03929432 (Treatment Outcomes With tDCS in Post-Stroke Aphasia) is: ACTIVE_NOT_RECRUITING.
When did Treatment Outcomes With tDCS in Post-Stroke Aphasia start?
Treatment Outcomes With tDCS in Post-Stroke Aphasia started on 2019-09-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.